why choose us

First received: September 01, 2023

Clinical Trial: Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Lactation Suppressed

Study Type: INTERVENTIONAL


Official Title: Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial

Brief Summary: Breast pain following second-trimester abortion is common.Breast engorgement and milk leakage following second-trimester perinatal loss and abortion can cause both physical pain and emotional distress.Dopamine agonists have previously been shown to be effective in lactation inhibition for third-trimester fetal/neonatal loss or contraindications to breastfeeding.The investigator's prior work demonstrated that compared to placebo, a single dose of cabergoline was effective in preventing breast symptoms…

Read more